sur BASTIDE (EPA:BLC)
The Bastide Group sells its subsidiary EXPERF to Sapio Group
On May 21, 2026, the Bastide Group announced the sale of its subsidiary New Medical Concept, the holding company of the EXPERF Group, to Sapio Group. EXPERF, part of the Bastide Group since 2017, doubled its revenue, reaching €42 million for the 2024-2025 fiscal year.
The sale is part of Bastide's asset optimization strategy. This transaction should help reduce the group's debt by improving its leverage ratio to slightly above 2.5x. The projected revenue of €510 million for the current fiscal year will not be affected.
Sapio, which is rapidly expanding in the healthcare sector, sees this acquisition as a key driver of its strategy in France. The completion of this transaction remains subject to customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE